IQVIA Holdings | IQV - Beneficio Bruto En Ventas





Beneficio Bruto En Ventas Cambio Fecha
Accenture USD 5.46B 737.76M 2025-12
Agilent USD 946M 44M 2025-12
Bruker USD 449.2M 69.8M 2025-12
Cardinal Health USD 2.4B 78M 2025-12
Celltrion KRW 626.11B 81.75B 2025-09
Charles River Laboratories USD 271.96M 39.43M 2025-12
Cigna USD 56.45B 50.29B 2025-09
Cognizant Technology Solutions USD 1.63B 25M 2026-03
Computer Programs Systems USD 35.62M 3.23M 2025-12
Cspc Pharmaceutical CNY 4.01B 329.18M 2025-12
CVS Health USD 13.57B 239M 2025-12
Danaher USD 3.59B 375M 2026-03
Dentsply International USD 443M 2M 2025-12
Deva Holding AS TRY 1.32B 235.77M 2023-09
Dianthus Therapeutics USD 284K 112K 2025-12
Divis Laboratories Ltd INR 16.59B 2.05B 2025-12
Elevance Health USD 11.68B 889M 2025-12
Humana USD 4.82B 754M 2025-06
IBM USD 9.19B 2.74B 2026-03
Illumina USD 759M 26M 2025-12
Infosys INR 143.44B 15.17B 2026-03
Kangmei Pharma CNY 270.29M 20.26M 2025-09
Knight Therapeutics CAD 64.72M 8.91M 2025-12
Laboratorios Farma EUR 105.28M 177.08M 2025-06
Laboratory Of America USD 993.2M 31.9M 2025-12
McKesson USD 3.68B 143M 2025-12
Mettler Toledo International USD 675.44M 65.98M 2025-12
Organigram Holdings CAD 23.32M 8.52M 2025-12
Pharma Mar EUR 86.7M 53.34M 2025-12
Publicis EUR 1.86B 235.5M 2025-06
Qiagen NV USD 325.27M 19.53M 2025-12
Quest Diagnostics USD 906M 33M 2026-03
Revvity USD 421.66M 47.06M 2025-12
Sartorius EUR 414.5M 18.3M 2026-03
Sino Biopharmaceutical CNY 10.5B 2.53B 2024-12
Thermo Fisher Scientific USD 4.49B 146M 2026-03
Tilray USD 57.47M 10.16M 2025-06
UnitedHealth USD 18.49B 2.14B 2025-12
Veeva Systems USD 622.47M 7.11M 2025-12
Veradigm USD 83.44M 3.95M 2022-09
Waters USD 557.42M 97.44M 2025-12
Zealand Pharma A/S 68.91M 19.35M 2025-12
Zz Pientze Pharmaceu CNY 296.13M 1.1B 2025-06